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Overview
by Vincent T. Devita, Jr.*
It is an honorto be here onthe occasion ofthe 40thAn-
niversary ofthe Institute ofEnvironmental Medicine of
the New York University Medical Center. The Institute
has been fortunate in its two Directors, Dr. Norton Nel-
sonand Dr. Arthur Upton. They should, individually and
together, take pride inthe quality, strength, and vitality
of the Institute.
The historyofthe Institute forEnvironmental Medicine
andthat ofthe National Cancer Institute are closely con-
nected. Dr. Arthur C. Upton, the Institute's director since
1980, preceded me as director ofthe National Cancer In-
stitute (NCI). Our personal linkage goes back even fur-
ther. I read an interview with Dr. Nelson in the NYU
Physician. He was describinghis "intense, butpolite" in-
terviewwith HomerSmith, amanhe admiredimmensely.
I, too, was influenced by Homer Smith during one sum-
mer at the Mount Desert Island Biological Laboratory
where I worked with C. Adrian Hogben. It was there I
met Dr. David Rall, who eventually brought me to NCI
and taught me all I know of pharmacology. I stayed at
NCI, and David Rallleftto headthe new Institute ofEn-
vironmental Health Sciences(NIEHS). Itwas there, also,
that I met Dr. Upton duringhis tenure as NCI Director,
and it was Dr. Upton who taught me all I know about
statesmanship, but as those ofyou who know both ofus
are aware, not all he knows about statesmanship. In afur-
ther bond, Dr. Rall and I are now proud that NCI and
NIEHS both support special centers at the Institute of
Environmental Medicine.
This year has been one ofcelebration andreview. In ad-
dition to the marking of40 years by the Institute ofEn-
vironmental Medicine, the National Institutes ofHealth
is 100 years old, the National Cancer Institute is 50years
old, and the National Cancer Act is 15 years old. This
reflective time isintensifiedby the fact thatthe Congress
willbegin hearings onthe reauthorization ofthe National
Cancer Act in the Spring. The key question often posed
to me has been, What has been the value of the Act?
In my view, the National Cancer Act has given us a
mandate to think of a world without cancer. It has also
challenged us to think of the National Cancer Institute
as a means to an end, not as an end in itself-a healthy
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view of institutions that could stand wider adoption.
These two mandates, when expressed outloud, inpublic,
often give rise to some concern about thinking that far
ahead, but in my view, the pace ofcurrent biological dis-
coveries actually demands that we dojust that. Scientif-
ically, it was amandate to undertake what couldbe called
"risky research," thatis, to workforbiggerpayoffs in the
longrun-in short, to brightenthefuture. Riskyprojects
such as work on cancerviruses andthe start ofthe search
forthe human cancervirusesgave usthe surprise ofviral
oncogenes; and then their cellular progenitors, the pro-
tooncogenes; and now, the anti-oncogenes, which promise
possible therapies that can halt cell division itself. Also,
because ofthe cancervirusprogram, NCI scientistswere
actively involved in research on the retroviruses when
AIDS came along. Thisgave us alegup on the discovery
oftheAIDSvirus[humanimmunodeficiency virus(HIV)],
as well as advancing work on treatment of AIDS and
eventually a vaccine.
Currently we are supporting a number ofprospective
prevention studies, considered scientifically risky by
some, butbased onourmassive supportforbasicresearch
in cancer causation. Studies are testing whether or not
interveningwith modifications ofdiets, micronutrients, or
chemotherapeutic agents will help prevent, halt, or re-
verse cancer progression in animals, or reduce the inci-
dence orriskofcancerinhumansexposed to carcinogens.
With the development of transgenic mice, we have an
ideal model forthe examination ofprospectiveprevention
at the laboratory level as well.
I am also often asked what the major scientific accom-
plishments ofthe CancerProgram have been. Without a
doubt, this program has given us a knowledge of cancer
biology undreamed ofin 1971. We are extremely close to
understanding the reasons that normal cells become
malignant. It appears that the uncontrolled growth we
know as cancer is a manifestation of normal genetically
controlled processes for growth and development gone
awry. Eventhe ultimately lethal process ofmetastasis ap-
pears to be an aberration ofthe normal migration func-
tion of embryonic cells, also under genetic control. The
good news isthatthese discrete genetic events appear to
be interruptible steps with our current level of tech-
nology.
We all knew much less about health and the environ-6 VT DEVITA, JR.
ment when Dr. Nelson came to the Institute in 1947. Dr.
Nelson hasrelated that, inthe early dayvs he andAnthony
Lanza planned that the Institute should.... convert the
basic science into useful and effective means toreduce the
likelihood ofoccupational disease...." The likelihood of
this farsighted wish coming true is brighter today than
ever before due to the biological revolution.
The most recent observation that recessive genes, sup-
pressor genes, or anti-oncogenes, as they are called by
some, notthe dominantoncogenes themselves, maybethe
essential elements inmaintainingorderinthe complex ar-
rangement of control of growth and development, and
their deletion or reduction to homozygosity may identify
those with asusceptibility to cancerisextraordinarily ex-
citing. From the point ofview ofenvironmental carcino-
genesis, thetools ofmoleculargenetics, likethese, nowof-
fer us the prospect of identifying persons who are at
special risk from exposure to carcinogens and should al-
low us to focus ourprevention efforts where they can do
the most good. The nation is fortunate to have an Insti-
tute ofEnvironmental Medicine readyandpoisedto take
advantage ofthe opportunities presented by such new in-
formation.
Again, I want to congratulate the Institute, and at the
same time, underline our common interests and empha-
size our responsibility to support and stimulate each
other. We cantake pride in ourcommon achievements and
continue to work toward the goal we share, framed ap-
propriately enough by Lewis Thomas in his book The
Medusa and the Snail. This paragraph bears on a facet
of the value of the National Cancer Act: the need for a
mandate to take scientific risks, and to think boldly ofa
world without cancer:
The brightest and most optimistic ofmy presentiments about
the future ofhuman health always seem to arouse a curious mix-
ture of resentment and dismay among some very intelligent
listenerm It is as though I'd said something bad about the future.
Actually, all I claim, partly on faith and partly from spotty but
unmistakable bits ofevidence out ofthe past century ofbiomed-
ical science, isthatmankind will somedaybe able to think hisway
around the finite list of major diseases that now close off life
prematurely orcause prolonged incapacitation andpain. In short,
we will someday be a disease-free species (1).
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